![Markus Haeberlein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markus Haeberlein
Direttore/Membro del Consiglio presso
XSPRAY PHARMA AB
Profilo
Markus Haeberlein is currently an Independent Director at Xspray Pharma AB since 2025 and Executive Vice President-Discovery Science at Parabilis Medicines, Inc. since 2024.
Former positions include Director & Head-Medicinal Chemistry at AstraZeneca LP, Senior Vice President-Research at Alkermes Plc, and Senior Vice President & Head-Research at Proteostasis Therapeutics, Inc. from 2012 to 2014.
Education includes graduate and doctorate degrees from the Royal Institute of Technology.
Posizioni attive di Markus Haeberlein
| Società | Posizione | Inizio |
|---|---|---|
| XSPRAY PHARMA AB | Direttore/Membro del Consiglio | 01/01/2025 |
| PARABILIS MEDICINES, INC. | Corporate Officer/Principal | 01/03/2024 |
Precedenti posizioni note di Markus Haeberlein
| Società | Posizione | Fine |
|---|---|---|
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Direttore/Membro del Consiglio | - |
| ALKERMES PLC | Direttore Tecnico/Scientifico/R&S | - |
| PROTEOSTASIS THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Markus Haeberlein
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
12
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
Xspray Pharma AB
 Xspray Pharma AB Pharmaceuticals: MajorHealth Technology Develops and produces particulate materials for the pharmaceutical industry | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Parabilis Medicines
 Parabilis Medicines Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for cancers and tumors | Health Technology |
